Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that two oral presentations and a poster presentation featuring data for the company’s NeXT ...

Republican lawmakers associated with the House Committee on Energy and Commerce are probing the 23andMe bankruptcy out of ...

ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI's Translational360™ and AI SaaS solutions, which use artificial intelligence and machine learning (AI/ML)-derived insights ...

From joint ventures to licensing deals, biotechnology is emerging as a strategic bridge between China and Japan.

With the advent of artificial intelligence (AI), predictive medicine is becoming an important part of health care, especially ...

M42 and Juvenescence will collaborate in drug discovery to develop a pipeline of innovative medicines to advance the ...

As the global population grows, the demand for food and energy is increasing even as extreme weather events make crops more ...

LONDON, UK I April 17, 2025 I GSK plc (LSE/NYSE: GSK) today announced the authorisation of Blenrep by the Medicines and Healthcare products Regulatory Agency ...

Fabric Genomics' cloud-native platform is expected to enable Genedx to deliver centralized AI interpretation while complying ...

Recent discoveries provide new insights into why Neanderthals became extinct around 40,000 years ago. Specifically, a study ...